Basic information |
Metabolite name | Docosapentaenoic acid (22n-3) |
HMDB0006528 | |
C16513 | |
5497182 | |
Synonyms | 7Z, 10Z, 13Z, 16Z, 19Z-Docosapentaenoic acid; |
No. of studies | 9 |
Relationship between Docosapentaenoic acid (22n-3) and depression (count: 9) |
Study | Study Type | Comparison groups | Tissue | Organism | Up/Down regulated |
Study M1019 | Type1 | depression group vs. control group | Serum | Human | Down |
Study M1045 | Type1 | depression group vs. control group | Plasma | Human | Down |
Study M1063 | Type1 | MDD group vs. control group | Plasma | Human | Down |
Study M1111 | Type1 | CUMS group vs. control group | Hippocampus | C57BL/6 mouse | Down |
Study M1111 | Type1 | CUMS group vs. control group | Plasma | C57BL/6 mouse | Down |
Study M1111 | Type3 | rTMS group vs. control group | Plasma | C57BL/6 mouse | Down |
Study M1111 | Type3 | rTMS group vs. control group | Hippocampus | C57BL/6 mouse | Down |
Study M469 | Type1 | Parkinson's disease with depression group vs. Parkinson's disease without depression group | Plasma | Human | Up |
Study M555 | Type1 | FMT group vs. control group | Liver | Sprague-Dawley rat | Up |
Study M600 | Type2 | high-fat diet + fish oil group vs. high-fat diet group | Forebrain | C57BL/6J mouse | Up |
Study M670 | Type2 | corticosterone + nicotinamide mononucleotide group vs. corticosterone group | Liver | C57/BL6 mouse | Down |
Study M869 | Type1 | CUMS group vs. control group | Peripheral blood mononuclear cell | Sprague-Dawley rat | Down |
Study M869 | Type2 | CUMS + middle dose of Chaigui granules group vs. CUMS group | Peripheral blood mononuclear cell | Sprague-Dawley rat | Up |
Study M869 | Type2 | CUMS + high dose of Chaigui granules group vs. CUMS group | Peripheral blood mononuclear cell | Sprague-Dawley rat | Up |